Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Am J Clin Oncol. 2015 Apr;38(2):152–158. doi: 10.1097/COC.0000000000000012

TABLE 2.

Clinicopathologic Variables of Patients According to MYC and TERC Gene Copy Status Based on the UCCC Criteria and ROC Classification

UCCC Criteria
ROC Classification
UCCC Criteria
ROC Classification
MYC FISH +
(n = 41,
36.2%)
MYC FISH −
(n = 72,
63.8%)
MYC≥2.83
(n = 60,
53.1%)
MYC<2.83
(n = 53,
46.9%)
TERC FISH +
(n = 41,
36.2%)
TERC FISH −
(n = 72,
63.8%)
TERC≥2.65
(n = 58,
51.3%)
TERC<2.65
(n = 55,
48.7%)
Sex, n (%)
 Female 6 (14.6) 12 (16.7) 9 (50.0) 9 (50.0) 4 (9.8) 14 (19.4) 7 (38.9) 11 (66.1)
 Male 35 (85.4) 60 (83.3) 51 (53.6) 44 (46.3) 37 (90.2) 58 (80.6) 51 (53.7) 44 (46.3)
P 1.0 0.77 0.28 0.25
 Smoking, n (%)
 Former/
  current
40 (97.6) 64 (88.9) 56 (53.8) 48 (46.3) 40 (97.6) 64 (88.9) 56 (53.8) 48 (46.2)
 Never 1 (2.4) 8 (11.1) 4 (44.4) 5 (55.6) 1 (2.4) 8 (11.1) 2 (22.2) 7 (77.8)
P 0.15 0.58 0.15 0.06
pTNM stage, n (%)
 I 25 (61.0) 45 (62.5) 39 (55.7) 31 (44.2) 24 (58.5) 46 (63.9) 36 (51.4) 34 (48.6)
 II 9 (22.0) 9 (12.5) 10 (55.6) 8 (44.8) 7 (17.1) 11 (15.3) 10 (55.6) 8 (44.4)
 III 7 (17.0) 18 (25.0) 11 (44.0) 14 (56.0) 10 (24.4) 15 (20.8) 12 (48.0) 13 (52.0)
P 0.32 0.58 0.81 0.88
Histology, n (%)
 Squamous 23 (56.1) 35 (48.1) 32 (55.2) 26 (44.8) 31 (75.6) 27 (37.5) 42 (72.4) 16 (27.6)
 Non 18 (43.9) 37 (51.4) 28 (50.9) 27 (40.1) 10 (24.4) 45 (62.5) 16 (29.1) 39 (20.9)
  Squamous
P 0.56 0.65 0.0001 < 0.0001
Grading, n (%)
 Well 2 (4.9) 10 (13.9) 6 (50.0) 6 (50.0) 3 (7.3) 9 (12.5) 6 (50.0) 6 (50.0)
 Moderately 19 (46.3) 32 (44.4) 27 (53.0) 24 (47.0) 20 (48.8) 31 (43.0) 24 (47.1) 27 (52.9)
 Poorly 20 (48.8) 30 (41.7) 27 (54.0) 23 (46.0) 18 (43.9) 32 (44.5) 25 (50.0) 25 (50.0)
P 0.34 0.56 0.72 0.95

FISH indicates fluorescence in situ hybridization; ROC, receiver operating characteristic classification; UCCC, The University of Colorado Cancer Center criteria.